Empery Asset Management, LP — 13F Holdings & Portfolio
CIK 1469336 · latest 13F-HR filed 2026-08-11
Empery Asset Management, LP manages $86.5M in 13F-reported U.S. long-equity assets across 32 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are XFOR (37.43%), EMPD (12.06%), NGEN (9.53%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 12 new positions and exited 12; 4 existing positions rose in reported value and 14 fell.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
Long-equity book
Distinct positions
Filed 2026-08-11
vs 2026-03-31
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
Portfolio map
Q2 26Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.
Sector mix
% of 13F valueSectors from each company's SIC code; funds and ETFs grouped separately.
Biggest buys and sells
Q1 26 → Q2 26Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.
13F assets and positions
3 quartersTotal reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.
Top positions over time
reported valueThe eight largest current positions, valued at each quarter end.
Concentration
top 10 = 90.7%Cumulative share of the portfolio held in the largest N positions.
As of the firm’s regulatory filing dated Mar 31, 2026.
SUITE 1205
NEW YORK CITY, NY 10020
| Name | Title / Status | Ownership | Type |
|---|---|---|---|
| DIRECTOR, BRETT, STEVEN Control | GENERAL COUNSEL & CHIEF COMPLIANCE OFFICER since Oct 2014 | Less than 5% | Individual |
| EMPERY AM GP, LLC Control | GENERAL PARTNER since Feb 2008 | Less than 5% | Domestic Entity |
| LANE, RYAN, MATTHEW Control | CHIEF INVESTMENT OFFICER AND CHIEF OPERATING OFFICER since Feb 2008 | 75% or more | Individual |
| LANE, RYAN, MATTHEW Control Indirect owner via EMPERY AM GP, LLC | MANAGING MEMBER since Feb 2008 | 75% or more | Individual |
Ownership & leadership changes · 3 filings with changes since May 31, 2012
From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.
- No longer listedHOE, MARTIN, D. · CHIEF INVESTMENT OFFICER · 25–50% · control person · listed since Feb 2008
- No longer listedHOE, MARTIN, D. · MANAGING MEMBER · 50–75% · indirect via EMPERY AM GP, LLC · control person · listed since Feb 2008
- ChangedLANE, RYAN, MATTHEW · title CHIEF OPERATING OFFICER → CHIEF INVESTMENT OFFICER AND CHIEF OPERATING OFFICER; ownership 25–50% → 75% or more
- ChangedLANE, RYAN, MATTHEW · indirect via EMPERY AM GP, LLC: ownership 50–75% → 75% or more
- AddedDIRECTOR, BRETT, STEVEN · GENERAL COUNSEL & CHIEF COMPLIANCE OFFICER · Less than 5% · control person
- AddedEMPERY AM GP, LLC · GENERAL PARTNER · Less than 5% · control person
- AddedHOE, MARTIN, D. · MANAGING MEMBER · 50–75% · indirect via EMPERY AM GP, LLC · control person
- AddedLANE, RYAN, MATTHEW · MANAGING MEMBER · 50–75% · indirect via EMPERY AM GP, LLC · control person
- ChangedHOE, MARTIN, D. · title MANAGING PARTNER → CHIEF INVESTMENT OFFICER; ownership 50–75% → 25–50%
- ChangedLANE, RYAN, MATTHEW · title MANAGING PARTNER → CHIEF OPERATING OFFICER; ownership 50–75% → 25–50%
- ChangedLANE, RYAN, MATTHEW · title MANAGING PARTNER/ CHIEF COMPLIANCE OFFICER → MANAGING PARTNER
- ListedHOE, MARTIN, D. · MANAGING PARTNER · 50–75% · control person
- ListedLANE, RYAN, MATTHEW · MANAGING PARTNER/ CHIEF COMPLIANCE OFFICER · 50–75% · control person
Quarter-over-quarter changes
Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.
Top Adds (vs prior quarter)
- RENATUS TACTICAL ACQUIS$15.0K +65.2%
- MARIS TECH LTD$13.1K +29.1%
- FGI INDUSTRIES LTD$5.3K +196.0%
- NEXERA TECHNOLOGIES LTD$4.3K +70.0%
Top Trims
- PRECISION BIOSCIENCES INC-$4.7M -43.7%
- X4 PHARMACEUTICALS INC-$4.6M -12.4%
- VENU HLDG CORP-$2.2M -65.1%
- EMPERY DIGITAL INC-$2.0M -15.8%
- JAGUAR URANIUM CORP-$526.5K -39.3%
New Positions
- NERVGEN PHARMA CORP$8.2M
- CLENE INC$5.6M
- ANNOVIS BIO INC$4.5M
- LANTERN PHARMA INC$3.5M
- AMC ENTMT HLDGS INC$3.3M
Exited Positions
- IMPERIAL PETE INC$3.8M
- U S ENERGY CORP DEL$1.7M
- SCYNEXIS INC$1.7M
- CRITICAL METALS CORP$1.0M
- PROMIS NEUROSCIENCES INC$766.5K
Empery Asset Management, LP Holdings (2026-06-30)
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | X4 PHARMACEUTICALS INC | XFOR | 98420X202 | $32.4M | 37.43% | 6,930,591 | SH |
| 2 | EMPERY DIGITAL INC | EMPD | 92864V608 | $10.4M | 12.06% | 2,930,345 | SH |
| 3 | NERVGEN PHARMA CORP | NGEN | 64082X203 | $8.2M | 9.53% | 4,000,000 | SH |
| 4 | PRECISION BIOSCIENCES INC | DTIL | 74019P207 | $6.1M | 7.05% | 776,093 | SH |
| 5 | CLENE INC | CLNN | 185634201 | $5.6M | 6.52% | 916,532 | SH |
| 6 | ANNOVIS BIO INC | ANVS | 03615A108 | $4.5M | 5.17% | 2,401,476 | SH |
| 7 | LANTERN PHARMA INC | LTRN | 51654W101 | $3.5M | 4.06% | 842,669 | SH |
| 8 | AMC ENTMT HLDGS INC | AMC | 00165C302 | $3.3M | 3.77% | 1,714,043 | SH |
| 9 | TENAYA THERAPEUTICS INC | TNYA | 87990A106 | $2.9M | 3.30% | 3,863,115 | SH |
| 10 | ONE AND ONE GREEN TECHNOLOGI | YDDL | G6772F102 | $1.5M | 1.78% | 761,706 | SH |
| 11 | CYNGN INC | CYN | 23257B305 | $1.3M | 1.49% | 927,059 | SH |
| 12 | VENU HLDG CORP | VENU | 92333E104 | $1.2M | 1.35% | 512,818 | SH |
| 13 | GREENLAND ENERGY CO | GLNDW | 70580B114 | $850.0K | 0.98% | 1,000,000 | SH |
| 14 | UR-ENERGY INC | URG | 91688R108 | $843.4K | 0.98% | 620,136 | SH |
| 15 | SATELLOS BIOSCIENCE INC | MSLE | 80401L803 | $832.7K | 0.96% | 107,100 | SH |
| 16 | JAGUAR URANIUM CORP | JAGU | 47010E108 | $814.1K | 0.94% | 487,500 | SH |
| 17 | CELLECTAR BIOSCIENCES INC | CLRB | 15117F880 | $527.1K | 0.61% | 189,605 | SH |
| 18 | SCYNEXIS INC | SCYX | 811292309 | $514.7K | 0.60% | 126,451 | SH |
| 19 | REIN THERAPEUTICS INC | RNTX | 00887A204 | $385.7K | 0.45% | 370,834 | SH |
| 20 | BTC DIGITAL LTD | BTCT | G6055H155 | $288.9K | 0.33% | 350,877 | SH |
| 21 | BRIACELL THERAPEUTICS CORP | BCTXL | 107930125 | $267.0K | 0.31% | 300,000 | SH |
| 22 | MARIS TECH LTD | MTEKW | M68057112 | $58.0K | 0.07% | 297,600 | SH |
| 23 | PARAZERO TECHNOLOGIES LTD | PRZO | M7S13T102 | $55.3K | 0.06% | 113,771 | SH |
| 24 | DUKE ROBOTICS CORP | DUKRW | 903448116 | $45.1K | 0.05% | 35,000 | SH |
| 25 | NUTRIBAND INC | NTRBW | 67092M125 | $40.2K | 0.05% | 40,218 | SH |
| 26 | RENATUS TACTICAL ACQUIS | RTACW | G7490F127 | $38.0K | 0.04% | 50,000 | SH |
| 27 | SPECTRAL AI INC | MDAIW | 84757T113 | $18.5K | 0.02% | 33,336 | SH |
| 28 | NEXERA TECHNOLOGIES LTD | NEXRW | M61472110 | $10.4K | 0.01% | 360,577 | SH |
| 29 | CEA INDUSTRIES INC | BNCWW | 86887P119 | $9.2K | 0.01% | 500,000 | SH |
| 30 | FGI INDUSTRIES LTD | FGIWW | G3302D111 | $8.0K | 0.01% | 83,928 | SH |
| 31 | NEUROSENSE THERAPEUTICS LTD | NRSNW | M74240116 | $6.3K | 0.01% | 100,402 | SH |
| 32 | NEXGEL INC | NXGLW | 65344E115 | $3.5K | 0.00% | 90,000 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-11 | $86.5M | 32 | 0000919574-26-004933 |
| 2026-03-31 | 2026-05-08 | $83.0M | 32 | 0000902664-26-002332 |
| 2025-12-31 | 2026-02-11 | $113.4M | 31 | 0000902664-26-000854 |
NEW YORK, NY 10020